Summary
The Cigna Group's 2024 Form 10-K highlights a year of significant operational activity and strategic repositioning. The company reported total revenues of $247.1 billion, a substantial increase driven primarily by growth in its Evernorth Health Services segment, particularly in Pharmacy Benefit Services. This segment saw a 32% increase in adjusted revenues, fueled by higher utilization and customer growth. However, the Cigna Healthcare segment experienced a decrease in pre-tax adjusted income from operations due to higher medical costs, which are impacting its medical care ratio. The company is in the process of divesting its Medicare Advantage and related businesses to HCSC, expected to close in early 2025, which will reshape its U.S. Healthcare segment. Financially, Cigna Group reported shareholders' net income of $3.4 billion, a decrease from the prior year, largely due to increased net investment losses, notably an impairment related to its VillageMD investment. Adjusted income from operations showed a modest 4% increase, reflecting the strength of Evernorth offsetting some of the pressures in Cigna Healthcare. The company continued its capital return strategy, repurchasing approximately $7 billion of its common stock in 2024 and maintaining its dividend payments, demonstrating a commitment to shareholder value despite the ongoing healthcare industry dynamics and specific business transformations.
Financial Highlights
51 data points| Revenue | $247.12B |
| Cost of Revenue | $182.51B |
| Gross Profit | $64.61B |
| SG&A Expenses | $14.84B |
| Operating Income | $9.42B |
| Interest Expense | $1.50B |
| Net Income | $3.43B |
| EPS (Basic) | $12.25 |
| EPS (Diluted) | $12.12 |
| Shares Outstanding (Diluted) | 283.22M |
Key Highlights
- 1Total revenues reached $247.1 billion, driven by a 32% increase in adjusted revenues for Evernorth Health Services, primarily from pharmacy services.
- 2Shareholders' net income decreased by 34% to $3.4 billion, impacted by significant net investment losses, including a $2.7 billion impairment of its VillageMD equity securities.
- 3Adjusted income from operations increased by 4% to $7.7 billion, reflecting growth in Evernorth Health Services offsetting a decline in Cigna Healthcare's segment income.
- 4Cigna Healthcare's medical care ratio increased by 190 basis points, largely due to higher medical costs, particularly in its stop-loss business, while U.S. Healthcare customers declined by 10%.
- 5The company is progressing with the sale of its Medicare Advantage and related businesses to HCSC, expected to close in the first quarter of 2025.
- 6Cigna Group repurchased approximately $7.0 billion of its common stock in 2024 and maintained its quarterly dividend payments, signaling a continued focus on capital return to shareholders.
- 7The company maintained a strong liquidity position, with $7.6 billion in cash and short-term investments and $6.5 billion in undrawn committed capacity under its revolving credit agreements as of December 31, 2024.